Bernhard Kreutzer

  • Citations Per Year
Learn More
Purpose: Current treatment of autoimmune endogenous posterior uveoretinitis (EPU) is limited by drug toxicity, unpredictable relapses on dose reduction and resistance to therapy. Administration of(More)
  • 1